Sign in

NCT03848962Recruiting

Collection and Distribution of Biospecimens for Novel Research Uses

iSpecimen Network Protocol: Collection and Distribution of Remnant and Research Use Only Biospecimens for Novel Research Uses

Source: ClinicalTrials.gov · Last updated 9 Nov 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").

Status (registry)
Recruiting
Study type
Observational
Enrollment
10000 (estimated)
First submitted
11 Feb 2019
Start date
30 Jun 2016
Primary completion date
31 Dec 2025
Lead sponsor
iSpecimen Inc
NCT number
NCT03848962

What you commit to

  • Study type: Observational
  • Planned participants: 10000
  • From 30 Jun 2016 to the primary completion date, 31 Dec 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Subjects that do not meet the inclusion criteria outlined above.

Who the study is looking for

  • Individual is developmentally aged 7 years old and above for RUO collections (only)
  • Individual meets requirements of a current request for research materials from iSpecimen
  • If a blood collection will be performed as part of the screening process or RUO collection, the individual's health will be assessed by medical staff through medical record review, clinical exam, and/or the review of an updated medical history as provided by the participant
  • Individual has reviewed and signed a consent form for an RUO specimen collection if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf.
  • Individual has reviewed and signed a consent form for remnant specimen usage in research if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf

Age in the registry: 1 month to 89 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
iSpecimen
Coordinator of this site? Confirm its status
HuntsvilleUnited StatesRecruiting
iSpecimen
Coordinator of this site? Confirm its status
LexingtonUnited StatesActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.